CerebrAlcare Pills on CereBral Small VesseL DiseasE（CABLE）

Summary

This is a randomized, double-blinded, placebo-controlled, multicenter trial. Cerebral small vessel disease (CSVD) patients will be diagnosed by Magnetic Resonance Imaging (MRI) and randomized into treatment or control groups. The purpose of this trial is to assess the efficacy of cerebralcare pills on cerebral small vessel disease.

Timeline

Start

2022-06-05

Primary completion

2023-12-31

Completion

2024-03-31

Publications

• Zhou M, Gong Y, Han S, Wang M, Gu W, Chen HS, Zheng W, Feng K, Wang D, Li H, Zheng Z, Pan Y, Chen W, Wang Y. CerebrAlcare Pills on CereBral Small VesseL DiseasE (CABLE) trial: rationale and design. Stroke Vasc Neurol. 2026 Apr 27;11(2):247-252. doi: 10.1136/svn-2024-003756.

Drugs

Indications